The science behind the cure for cancer is more intricate than previous belief. Eric Lefkofsky explains how obtaining more data in new areas could be the cure for cancer. At the Fortune Brainstorm Health conference, Lefkofsky states that a doctor should know more about the patients that they are helping than their molecular foundations. More questions should be asked such as “are they diabetic?” or “are they on other drugs.” Sharing the data quickly and effectively between those who require access to it is just as important to know the answers to these questions.
Lefkofsky has made 103 investments in 74 companies leading to a net worth of $1.65 billion. He graduated with his Juris Doctor from the University of Michigan Law School and later became a professor at the University of Chicago. He is also the author of the book Accelerated Disruption. Lefkofsky is the co-founder of many companies including Groupon, and he is also the co-founder and CEO of Tempus which is a company focused on revolutionizing cancer treatment. The company has created an operating system that is being used to combat cancer. The official Tempus website states that this system is a “library of molecular and clinical data and an operating system to make the data accessible and useful.” Doctors working with this technology understand that each patient and each illness is unique and should be treated as such.
He and his wife, Liz, also created the Lefkofsky Family Foundation to support organizations that provide and promote scientific education. They are both a part of the Giving Pledge, which is a commitment to philanthropy by some of the wealthiest in the world. Much of their charitable work is based in their Chicago area with a focus on the issues of education and health although their largest donation was a $7 million contribution the arts. With Eric and Liz Lefkofsky’scharitability, the cure for cancer may be closer than expected.